Sök
To news
Mandates | 2020-09-10

TM & Partners has advised the sellers in connection with the sale of MittVaccin to Cambio

TM & Partners has advised the sellers in connection with the sale of MittVaccin Sverige AB to Cambio Healthcare Systems AB. Through the sale, MittVaccin becomes a subsidiary of Cambio Healthcare Systems and the parties ambition is to jointly accelerate the efforts to achieve MittVaccin’s vision “a patient-safe and efficient handling of vaccinations”.

TM & Partners teams comprised:

Related
Aktiediagram
Törngren Magnell biträdde vid försäljningen av Envirotainer
Törngren Magnell has assisted Apoteket in investment in Doktor24
Digitala diagram
TM & Partners advises Posti group on divestment of Posti Messaging Scandinavia to Ropo Capital
Aktiediagram
Törngren Magnell biträdde vid försäljningen av Envirotainer
Törngren Magnell has assisted Apoteket in investment in Doktor24
Digitala diagram
TM & Partners advises Posti group on divestment of Posti Messaging Scandinavia to Ropo Capital
Cookie policy
TM & Partners

This website uses cookies in order to perform certain services and to help you as a user to navigate the site in an efficient manner. A cookie is a text file containing a small amount of information that is stored on your device provided your consent. For more information, please refer to Cookie Policy.

Necessary Cookies

Cookies necessary for remembering your cookie-preferences.

Performance cookies

Performance cookies are cookies used specifically for gathering data on how visitors use a website, which pages of a website are visited most often, or if they get error messages on web pages. These cookies monitor only the performance of the site as the user interacts with it. These cookies do not collect identifiable information on visitors, which means all the data collected is anonymous and only used to improve the functionality of a website.